Filters
A genetically engineered pig liver has been successfully transplanted in a living human, according to a recent study, noting the challenge posed by postoperative xenotransplantation-associated thrombotic microangiopathy (xTMA) to long-term success.
Excess parental adiposity prior to pregnancy is associated with increased likelihood of metabolic dysfunction-associated steatotic liver disease (MASLD) development in offspring as adults, as mediated by higher BMI throughout childhood, according to a study.
Even light or moderate consumption of alcohol can still increase the risk of steatotic liver disease (SLD) and its metabolic dysfunction-associated subtype (MASLD), suggests a study. Furthermore, a gut microbial score based on alcohol-associated species predicts a higher disease risk.
Patients with hepatocellular carcinoma (HCC) who develop immune-related adverse events (irAEs) following treatment with an immune checkpoint inhibitor (ICI) tend to have more favourable clinical outcomes, including better progression free survival (PFS) and objective response rate (ORR), reports a recent study.
Rural area residents have seen greater increases in hepatocellular carcinoma (HCC) deaths each year than those living in urban areas, reveals a study.
Endoscopic retrograde cholangiopancreatography (ERCP), although deemed safe, is associated with the highest risk of complications when compared with other endoscopic procedures, reveals a study.
A 15-year study recommends taking into consideration the differential risks of hepatitis B virus (HBV) and hepatitis C virus (HCV) reactivations when choosing targeted therapies for the treatment of psoriasis and psoriatic arthritis (PsA), particularly in patients with risk factors for viral reactivation.
The use of the 2022 ESC/ERC definitions of pulmonary arterial hypertension (PAH) has led to the identification of cirrhosis patients with early-stage portopulmonary hypertension (PoPH), who are at greater risk of death, reports a study.
Patients with metabolic dysfunction-associated steatotic liver disease (MASLD), who also happen to have hypertension, are at much greater risk of adverse clinical outcomes and progression of liver stiffness and fibrosis, according to a study.
Patients with potentially resectable hepatocellular carcinoma (HCC) may receive neoadjuvant nivolumab plus ipilimumab therapy, followed by surgery, to improve their survival, suggests a study.